Table 2.

Crude and age- and sex-standardized prevalence and incidence of psoriatic arthritis in Israel by year (2006–2015)

Year	Prevalence of PsA				Incidence of PsA
	Total population (N)	PsA (n)	Crude prevalence (%)	Standardized prevalence (%) (95% CI)^a	New PsA (n)	Crude incidence#	Standardized incidence^a (95% CI)^b
2006	2,620,136	1910	0.073	0.067 (0.065, 0.070)	277	10.6	10.4 (9.5, 11.4)
2007	2,648,067	2132	0.081	0.075 (0.072, 0.077)	251	9.8	9.3 (8.4, 10.3)
2008	2,676,404	2425	0.091	0.084 (0.081, 0.086)	308	11.5	11.4 (10.4, 12.4)
2009	2,705,397	2663	0.098	0.091 (0.088, 0.093)	278	10.3	10.1 (9.2, 11.1)
2010	2,734,705	2938	0.107	0.099 (0.096, 0.102)	303	11.1	11.1 (10.1, 12.1)
2011	2,777,279	3237	0.117	0.107 (0.104, 0.110)	330	11.9	11.7 (10.8, 11.8)
2012	2,816,452	3531	0.125	0.114 (0.111, 0.117)	382	12.5	12.3 (11.3, 13.3)
2013	2,861,934	3866	0.135	0.122 (0.119, 0.125)	354	13.4	13.1 (12.0, 14.1)
2014	2,905,530	4223	0.145	0.131 (0.128, 0.134)	404	13.9	13.5 (12.5, 14.6)
2015	2,931,199	4490	0.153	0.137 (0.134, 0.141)	322	11.0	10.6 (9.7, 11.6)

PsA Psoriatic arthritis

^aAge- and sex-standardized to Israel population in 2006

^bCrude and standardized rates are per 100,000 population